Streptomycin perfusion of the labyrinth

Area of Science:

• Otolaryngology
• Neurology
• Immunology

Background:

• Meniere's disease is characterized by hearing loss, tinnitus, and vertigo.
• Endolymphatic hydrops is the presumed cause, but not all cases align.
• An unknown immune-mediated factor may contribute to Meniere's disease.

Purpose of the Study:

• To explore potential causes of Meniere's disease beyond endolymphatic hydrops.
• To evaluate the efficacy of current treatments for Meniere's disease.
• To investigate streptomycin as a direct treatment for Meniere's disease symptoms.

Main Methods:

• Review of clinical presentations and pathological findings in Meniere's disease.
• Analysis of the effectiveness of medical (diet, diuretics, steroids) and surgical treatments.
• Examination of streptomycin's effect on vestibular receptors, referencing animal studies.

Main Results:

• Endolymphatic hydrops is present in most, but not all, Meniere's disease patients.
• Conventional treatments offer limited long-term benefit for vertigo and hearing loss.
• Streptomycin effectively relieves dizzy attacks by selectively destroying vestibular receptors.

Conclusions:

• Meniere's disease likely has an immune-mediated component exacerbating endolymphatic hydrops.
• Surgical interventions like vestibular neurectomy are risky and do not improve hearing.
• Streptomycin presents a direct, effective method for controlling vertigo in Meniere's disease.